Jan 19 (Reuters) - The U.S. health regulator said on Wednesday it was expanding the medical device shortage list to include all blood specimen collection tubes due to supply challenges led by an ...

Drug makers sign on to help produce Merck’s COVID-19 pill for developing countries; research shows promise for organ transplants from genetically modified pigs; blood sample collection tubes added to ...

Liquid biopsies have emerged as a powerful tool in modern medicine, enabling non-invasive detection and monitoring of diseases such as cancer. At the forefront of this revolution are the BD PAXgene ® ...

Credit: Becton, Dickinson and Company. The system consists of a capillary blood collection tube and a finger sleeve that is intended for use by a trained health care provider, without the need of a ...

Novel innovations for stabilizing the plasma proteome in whole blood samples provide researchers with more confidence in their protein analysis. To reduce the preanalytical variability, scientists can ...

The plasma proteome is a rich source of potential biomarkers for diseases, such as cancer and neurodegenerative disorders. To assess these proteins, scientists commonly draw whole blood samples into ...

Every blood sample begins degrading the moment it's drawn, and most of what can go wrong with a laboratory result goes wrong before the specimen ever reaches an analyzer. This is the preanalytical ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) - The U.S. health regulator said on ...